Applying the grades of recommendation for antithrombotic and thrombolytic therapy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Chest
Gordon H GuyattStephen Pauker

Abstract

This article about the grades of recommendation for antithrombotic and thrombolytic therapy is part of the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines. Clinicians need to know whether a recommendation is strong or weak, and about the methodological quality of the evidence underlying that recommendation. We determine the strength of a recommendation by considering the trade-off between the benefits of a treatment, on the one hand, and the risks, burdens, and costs on the other. Here, as elsewhere, we assume that a recommended treatment will increase costs (we recognize this is not always the case, but for simplicity we will continue to make this assumption). If the benefits outweigh the risks, burdens, and costs, we recommend that clinicians offer a treatment to typical patients. The uncertainty associated with the trade-off between the benefits and the risks, burdens, and costs will determine the strength of the recommendations. If we are very certain that the benefits do, or do not, outweigh the risks, burdens, and costs, we make a strong recommendation (in our formulation, Grade 1). If we are less certain of the magnitude of the benefits and the...Continue Reading

References

Mar 20, 1997·The New England Journal of Medicine·R CollinsP Sleight
Feb 7, 2001·Chest·G GuyattUNKNOWN American College of Chest Physicians
Feb 7, 2001·Chest·M R Jackson, G P Clagett

❮ Previous
Next ❯

Citations

Dec 7, 2007·Intensive Care Medicine·R Phillip DellingerJean-Louis Vincent
Dec 5, 2008·Wiener medizinische Wochenschrift·Christoph Pechlaner, Michael Joannidis
Feb 14, 2006·Journal of Thrombosis and Thrombolysis·Alex C Spyropoulos
Jun 8, 2010·Surgical Infections·John C MarshallMitchell Levy
Dec 26, 2007·Critical Care Medicine·R Phillip DellingerUNKNOWN World Federation of Societies of Intensive and Critical Care Medicine
Jul 3, 2008·Plastic and Reconstructive Surgery·Daniel A HatefSpencer A Brown
Apr 11, 2009·Drugs & Aging·Cheryl D Bushnell, Cathleen S Colón-Emeric
Apr 3, 2009·Journal of Neurosurgery. Pediatrics·Shobhan VachhrajaniJohn R W Kestle
Dec 24, 2013·Cirugía española·José Luis Aguayo-AlbasiniVíctor Soria-Aledo
Jun 4, 2005·European Journal of Pediatrics·Marc van HeerdeFrans B Plötz
Mar 1, 2007·Women's Health·Rainer B ZotzRüdiger E Scharf
Jun 18, 2009·Medizinische Klinik·Norbert Maurin
Jul 9, 2010·Current Opinion in Allergy and Clinical Immunology·Luigi TerraccianoHolger Schünemann
May 9, 2008·Journal of Pediatric Gastroenterology and Nutrition·Jacek MrukowiczUNKNOWN European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)
Nov 15, 2011·Journal of Clinical Epidemiology·Elie A AklHolger J Schünemann
Feb 6, 2007·La Presse médicale·Patrick MismettiSilvy Laporte
Apr 14, 2007·Clinics in Podiatric Medicine and Surgery·Sondra VaziraniDavid Aungst
Aug 25, 2009·Pharmacotherapy·Craig I ColemanC Michael White
Nov 29, 2012·Geriatrics & Gerontology International·Frederic BlochGilles Kemoun
Jun 12, 2013·Journal of Paediatrics and Child Health·Annaleise R Howard-Jones, David Isaacs
Feb 21, 2006·Injury·B A PetrisorE Schemitsch
Sep 6, 2005·Thrombosis Research·Andreas Greinacher, Theodore E Warkentin
Apr 14, 2005·Annales Françaises D'anesthèsie Et De Rèanimation·G GodetT Cristea
Oct 16, 2007·The American Journal of Medicine·Amjad Almahameed, Teresa L Carman
Jul 19, 2006·Current Medical Research and Opinion·Alex C SpyropoulosMarc Cohen
Jun 9, 2005·The Annals of Pharmacotherapy·Donald F BrophyA Scott Mathis
May 1, 2007·The Veterinary Clinics of North America. Small Animal Practice·Kari V Lunsford, Andrew J Mackin
Sep 13, 2007·The Annals of Otology, Rhinology, and Laryngology·Stephanie M ColeCraig L Cupp
Feb 27, 2016·Phlebology·Patrick Navin, Gerard J O'Sullivan
Aug 17, 2006·The Annals of Pharmacotherapy·Edith A NutescuWilliam E Dager
Nov 21, 2007·Journal of Clinical Pharmacy and Therapeutics·Y HassanO Ismail
Feb 19, 2020·Journal of Wound Care·Jan StryjaDeborah Xuereb
Mar 23, 2006·Dimensions of Critical Care Nursing : DCCN·Wendy Kehl-Pruett
Sep 24, 2005·Cancer Control : Journal of the Moffitt Cancer Center·Howard A Liebman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.